SPX4,305.20+8.06 0.19%
DIA341.77+2.40 0.71%
IXIC13,102.55-25.50 -0.19%

Amedisys Sees FY22 Adj. Net Service Revenue $2.29B-$2.31B; Reaffirms Adj. EPS Guidance $5.23-$5.45

We are updating our previously issued revenue guidance: Adjusted net service revenue is anticipated to be in the range of $2.290 billion to $2.310 billion. We are reaffirming our previously issued EBITDA and

Benzinga · 07/27/2022 16:22

We are updating our previously issued revenue guidance:

  • Adjusted net service revenue is anticipated to be in the range of $2.290 billion to $2.310 billion.

We are reaffirming our previously issued EBITDA and earnings per share guidance:

  • Adjusted EBITDA is anticipated to be in the range of $275 million to $285 million.
  • Adjusted diluted earnings per share is anticipated to be in the range of $5.23 to $5.45 based on an estimated 32.8 million shares outstanding.